Setting

Global Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248436 | Pages: 198

Global clinical trials market will reach $ 79,977.1 million by 2031, growing by 6.8% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 88 tables and 111 figures, this 198-page report “Global Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Region. Based on Product Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Trials of Drugs o Small Molecule Drugs o Vaccines o Cell & Gene Therapy o Other Drugs • Trials of Devices • Trials of Procedures Based on Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Phase I • Phase II • Phase III • Phase IV By Design, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Interventional Studies o Randomized Control Trial o Adaptive Clinical Trial o Non-randomized Control Trial • Observational Studies o Cohort Study o Case Control Study o Cross Sectional Study o Ecological Study • Expanded Access Trials By Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Protocol Designing • Site Identification • Patient Recruitment • Laboratory Services • Bioanalytical Testing Services • Clinical Trial Data Management Services • Clinical Trial Supply & Logistic Services • Decentralized Clinical Trial Services • Medical Device Testing Services • Other Clinical Trial Services By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Infectious Diseases • Cardiology • Obesity • Diabetes • Neurology • Immunology • Pain Management • Other Indications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical and Biotechnological Companies • Clinical Research Organizations • Clinical Testing Laboratories • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Phase, Design, and Indication over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Accell Clinical Research LLC Charles River Laboratory ClinDatrix Inc Clinipace Eli Lilly and Company F. Hoffmann-La Roche Ltd. ICON PLC IQVIA Holdings, Inc. Laboratory Corporation of America Novo Nordisk AS PAREXEL International Corporation Pfizer Inc. Pharmaceutical Product Development LLC PRA Health Sciences Sanofi SA SGS SA Syneos Health Inc. Wuxi AppTec Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

10 1.1 Industry Definition and Research Scope 10 1.1.1 Industry Definition 10 1.1.2 Research Scope 11 1.2 Research Methodology 14 1.2.1 Overview of Market Research Methodology 14 1.2.2 Market Assumption 15 1.2.3 Secondary Data 15 1.2.4 Primary Data 15 1.2.5 Data Filtration and Model Design 16 1.2.6 Market Size/Share Estimation 17 1.2.7 Research Limitations 18 1.3 Executive Summary 19 2 Market Overview and Dynamics 22 2.1 Market Size and Forecast 22 2.1.1 Impact of COVID-19 on World Economy 24 2.1.2 Impact of COVID-19 on the Market 26 2.2 Major Growth Drivers 28 2.3 Market Restraints and Challenges 35 2.4 Emerging Opportunities and Market Trends 38 2.5 Porter’s Fiver Forces Analysis 42 3 Segmentation of Global Market by Product Category 46 3.1 Market Overview by Product Category 46 3.2 Trials of Drugs 48 3.2.1 Small Molecule Drugs 49 3.2.2 Vaccines 50 3.2.3 Cell & Gene Therapy 51 3.2.4 Other Drugs 52 3.3 Trials of Devices 53 3.4 Trials of Procedures 54 4 Segmentation of Global Market by Phase 55 4.1 Market Overview by Phase 55 4.2 Phase I 57 4.3 Phase II 58 4.4 Phase III 59 4.5 Phase IV 60 5 Segmentation of Global Market by Design 61 5.1 Market Overview by Design 61 5.2 Interventional Studies 63 5.2.1 Randomized Control Trial 65 5.2.2 Adaptive Clinical Trial 66 5.2.3 Non-randomized Control Trial 67 5.3 Observational Studies 68 5.3.1 Cohort Study 70 5.3.2 Case Control Study 71 5.3.3 Cross Sectional Study 72 5.3.4 Ecological Study 73 5.4 Expanded Access Trials 74 6 Segmentation of Global Market by Service Type 75 6.1 Market Overview by Service Type 75 6.2 Protocol Designing 77 6.3 Site Identification 78 6.4 Patient Recruitment 79 6.5 Laboratory Services 80 6.6 Bioanalytical Testing Services 81 6.7 Clinical Trial Data Management Services 82 6.8 Clinical Trial Supply & Logistic Services 83 6.9 Decentralized Clinical Trial Services 84 6.10 Medical Device Testing Services 85 6.11 Other Clinical Trial Services 86 7 Segmentation of Global Market by Indication 87 7.1 Market Overview by Indication 87 7.2 Oncology 89 7.3 Infectious Diseases 90 7.4 Cardiology 91 7.5 Obesity 92 7.6 Diabetes 93 7.7 Neurology 94 7.8 Immunology 95 7.9 Pain Management 96 7.10 Other Indications 97 8 Segmentation of Global Market by End User 98 8.1 Market Overview by End User 98 8.2 Pharmaceutical and Biotechnological Companies 100 8.3 Clinical Research Organizations 101 8.4 Clinical Testing Laboratories 102 8.5 Other End Users 103 9 Segmentation of Global Market by Region 104 9.1 Geographic Market Overview 2021-2031 104 9.2 North America Market 2021-2031 by Country 108 9.2.1 Overview of North America Market 108 9.2.2 U.S. 112 9.2.3 Canada 115 9.2.4 Mexico 117 9.3 European Market 2021-2031 by Country 119 9.3.1 Overview of European Market 119 9.3.2 Germany 123 9.3.3 U.K. 125 9.3.4 France 127 9.3.5 Spain 129 9.3.6 Italy 131 9.3.7 Russia 133 9.3.8 Rest of European Market 135 9.4 Asia-Pacific Market 2021-2031 by Country 137 9.4.1 Overview of Asia-Pacific Market 137 9.4.2 Japan 141 9.4.3 China 144 9.4.4 Australia 146 9.4.5 India 148 9.4.6 South Korea 150 9.4.7 Rest of APAC Region 152 9.5 South America Market 2021-2031 by Country 154 9.5.1 Argentina 157 9.5.2 Brazil 159 9.5.3 Chile 161 9.5.4 Rest of South America Market 163 9.6 MEA Market 2021-2031 by Country 164 9.6.1 UAE 167 9.6.2 Saudi Arabia 169 9.6.3 South Africa 171 9.6.4 Other National Markets 173 10 Competitive Landscape 174 10.1 Overview of Key Vendors 174 10.2 New Product Launch, Partnership, Investment, and M&A 178 10.3 Company Profiles 179 Accell Clinical Research LLC 179 Charles River Laboratory 181 ClinDatrix Inc 182 Clinipace 183 Eli Lilly and Company 184 F. Hoffmann-La Roche Ltd. 185 ICON PLC 186 IQVIA Holdings, Inc. 187 Laboratory Corporation of America 188 Novo Nordisk AS 189 PAREXEL International Corporation 190 Pfizer Inc. 191 Pharmaceutical Product Development LLC 192 PRA Health Sciences 193 Sanofi SA 194 SGS SA 195 Syneos Health Inc. 196 Wuxi AppTec Inc. 197 RELATED REPORTS 198
List Of Tables:
Table 1. Snapshot of Global Clinical Trials Market in Balanced Perspective, 2021-2031 20 Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021 23 Table 3. World Economic Outlook, 2021-2031 25 Table 4. World Health Spending by Region, $ bn, 2013-2020 34 Table 5. Main Product Trends and Market Opportunities in Global Clinical Trials Market 38 Table 6. Global Clinical Trials Market by Product Category, 2021-2031, $ mn 46 Table 7. Global Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn 48 Table 8. Global Clinical Trials Market by Phase, 2021-2031, $ mn 55 Table 9. Global Clinical Trials Market by Design, 2021-2031, $ mn 61 Table 10. Global Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn 64 Table 11. Global Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn 69 Table 12. Global Clinical Trials Market by Service Type, 2021-2031, $ mn 75 Table 13. Global Clinical Trials Market by Indication, 2021-2031, $ mn 87 Table 14. Global Clinical Trials Market by End User, 2021-2031, $ mn 98 Table 15. Global Clinical Trials Market by Region, 2021-2031, $ mn 105 Table 16. Leading National Clinical Trials Market, 2021 and 2031, $ mn 107 Table 17. North America Clinical Trials Market by Country, 2021-2031, $ mn 110 Table 18. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn 114 Table 19. U.S. Clinical Trials Market by Design, 2021-2031, $ mn 114 Table 20. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn 114 Table 21. Canada Clinical Trials Market by Phase, 2021-2031, $ mn 116 Table 22. Canada Clinical Trials Market by Design, 2021-2031, $ mn 116 Table 23. Canada Clinical Trials Market by Indication, 2021-2031, $ mn 116 Table 24. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn 118 Table 25. Mexico Clinical Trials Market by Design, 2021-2031, $ mn 118 Table 26. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn 118 Table 27. Europe Clinical Trials Market by Country, 2021-2031, $ mn 122 Table 28. Germany Clinical Trials Market by Phase, 2021-2031, $ mn 124 Table 29. Germany Clinical Trials Market by Design, 2021-2031, $ mn 124 Table 30. Germany Clinical Trials Market by Indication, 2021-2031, $ mn 124 Table 31. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn 126 Table 32. U.K. Clinical Trials Market by Design, 2021-2031, $ mn 126 Table 33. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn 126 Table 34. France Clinical Trials Market by Phase, 2021-2031, $ mn 128 Table 35. France Clinical Trials Market by Design, 2021-2031, $ mn 128 Table 36. France Clinical Trials Market by Indication, 2021-2031, $ mn 128 Table 37. Spain Clinical Trials Market by Phase, 2021-2031, $ mn 130 Table 38. Spain Clinical Trials Market by Design, 2021-2031, $ mn 130 Table 39. Spain Clinical Trials Market by Indication, 2021-2031, $ mn 130 Table 40. Italy Clinical Trials Market by Phase, 2021-2031, $ mn 132 Table 41. Italy Clinical Trials Market by Design, 2021-2031, $ mn 132 Table 42. Italy Clinical Trials Market by Indication, 2021-2031, $ mn 132 Table 43. Russia Clinical Trials Market by Phase, 2021-2031, $ mn 134 Table 44. Russia Clinical Trials Market by Design, 2021-2031, $ mn 134 Table 45. Russia Clinical Trials Market by Indication, 2021-2031, $ mn 134 Table 46. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn 136 Table 47. APAC Clinical Trials Market by Country, 2021-2031, $ mn 139 Table 48. Japan Clinical Trials Market by Phase, 2021-2031, $ mn 143 Table 49. Japan Clinical Trials Market by Design, 2021-2031, $ mn 143 Table 50. Japan Clinical Trials Market by Indication, 2021-2031, $ mn 143 Table 51. China Clinical Trials Market by Phase, 2021-2031, $ mn 145 Table 52. China Clinical Trials Market by Design, 2021-2031, $ mn 145 Table 53. China Clinical Trials Market by Indication, 2021-2031, $ mn 145 Table 54. Australia Clinical Trials Market by Phase, 2021-2031, $ mn 147 Table 55. Australia Clinical Trials Market by Design, 2021-2031, $ mn 147 Table 56. Australia Clinical Trials Market by Indication, 2021-2031, $ mn 147 Table 57. India Clinical Trials Market by Phase, 2021-2031, $ mn 149 Table 58. India Clinical Trials Market by Design, 2021-2031, $ mn 149 Table 59. India Clinical Trials Market by Indication, 2021-2031, $ mn 149 Table 60. South Korea Clinical Trials Market by Phase, 2021-2031, $ mn 151 Table 61. South Korea Clinical Trials Market by Design, 2021-2031, $ mn 151 Table 62. South Korea Clinical Trials Market by Indication, 2021-2031, $ mn 151 Table 63. Clinical Trials Market in Rest of APAC by Country/Region, 2021-2031, $ mn 153 Table 64. South America Clinical Trials Market by Country, 2021-2031, $ mn 156 Table 65. Argentina Clinical Trials Market by Phase, 2021-2031, $ mn 158 Table 66. Argentina Clinical Trials Market by Design, 2021-2031, $ mn 158 Table 67. Argentina Clinical Trials Market by Indication, 2021-2031, $ mn 158 Table 68. Brazil Clinical Trials Market by Phase, 2021-2031, $ mn 160 Table 69. Brazil Clinical Trials Market by Design, 2021-2031, $ mn 160 Table 70. Brazil Clinical Trials Market by Indication, 2021-2031, $ mn 160 Table 71. Chile Clinical Trials Market by Phase, 2021-2031, $ mn 162 Table 72. Chile Clinical Trials Market by Design, 2021-2031, $ mn 162 Table 73. Chile Clinical Trials Market by Indication, 2021-2031, $ mn 162 Table 74. MEA Clinical Trials Market by Country, 2021-2031, $ mn 166 Table 75. UAE Clinical Trials Market by Phase, 2021-2031, $ mn 168 Table 76. UAE Clinical Trials Market by Design, 2021-2031, $ mn 168 Table 77. UAE Clinical Trials Market by Indication, 2021-2031, $ mn 168 Table 78. Saudi Arabia Clinical Trials Market by Phase, 2021-2031, $ mn 170 Table 79. Saudi Arabia Clinical Trials Market by Design, 2021-2031, $ mn 170 Table 80. Saudi Arabia Clinical Trials Market by Indication, 2021-2031, $ mn 170 Table 81. South Africa Clinical Trials Market by Phase, 2021-2031, $ mn 172 Table 82. South Africa Clinical Trials Market by Design, 2021-2031, $ mn 172 Table 83. South Africa Clinical Trials Market by Indication, 2021-2031, $ mn 172 Table 84. Percentage of Registered Studies by Location (as of February 24, 2022) 176 Table 85. Percentage of Recruiting Studies by Location (as of February 24, 2022) 176 Table 86. Accell Clinical Research LLC: Company Snapshot 179 Table 87. Accell Clinical Research LLC: Business Segmentation 180 Table 88. Accell Clinical Research LLC: Product Portfolio 180
List Of Figures:
Figure 1. Research Method Flow Chart 14 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17 Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19 Figure 4. Global Clinical Trials Market, 2021-2031, $ mn 22 Figure 5. Impact of COVID-19 on Business 26 Figure 6. Primary Drivers and Impact Factors of Global Clinical Trials Market 28 Figure 7. Percentage of Trial Participants by Country, 2015-2019 31 Figure 8. Leading Causes of Death in the World, 2019-2020, million 32 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33 Figure 11. Primary Restraints and Impact Factors of Global Clinical Trials Market 35 Figure 12. Investment Opportunity Analysis 39 Figure 13. Porter’s Fiver Forces Analysis of Global Clinical Trials Market 42 Figure 14. Breakdown of Global Clinical Trials Market by Product Category, 2021-2031, % of Revenue 47 Figure 15. Global Addressable Market Cap in 2022-2031 by Product Category, Value ($ mn) and Share (%) 47 Figure 16. Global Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn 48 Figure 17. Global Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn 49 Figure 18. Global Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn 50 Figure 19. Global Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn 51 Figure 20. Global Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn 52 Figure 21. Global Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn 53 Figure 22. Global Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn 54 Figure 23. Breakdown of Global Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue 56 Figure 24. Global Addressable Market Cap in 2022-2031 by Phase, Value ($ mn) and Share (%) 56 Figure 25. Global Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn 57 Figure 26. Global Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn 58 Figure 27. Global Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn 59 Figure 28. Global Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn 60 Figure 29. Breakdown of Global Clinical Trials Market by Design, 2021-2031, % of Sales Revenue 62 Figure 30. Global Addressable Market Cap in 2022-2031 by Design, Value ($ mn) and Share (%) 62 Figure 31. Global Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn 63 Figure 32. Global Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn 65 Figure 33. Global Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn 66 Figure 34. Global Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn 67 Figure 35. Global Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn 68 Figure 36. Global Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn 70 Figure 37. Global Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn 71 Figure 38. Global Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn 72 Figure 39. Global Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn 73 Figure 40. Global Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn 74 Figure 41. Breakdown of Global Clinical Trials Market by Service Type, 2021-2031, % of Revenue 76 Figure 42. Global Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%) 76 Figure 43. Global Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn 77 Figure 44. Global Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn 78 Figure 45. Global Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn 79 Figure 46. Global Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn 80 Figure 47. Global Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn 81 Figure 48. Global Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn 82 Figure 49. Global Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn 83 Figure 50. Global Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn 84 Figure 51. Global Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn 85 Figure 52. Global Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn 86 Figure 53. Breakdown of Global Clinical Trials Market by Indication, 2021-2031, % of Revenue 88 Figure 54. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 88 Figure 55. Global Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn 89 Figure 56. Global Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn 90 Figure 57. Global Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn 91 Figure 58. Global Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn 92 Figure 59. Global Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn 93 Figure 60. Global Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn 94 Figure 61. Global Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn 95 Figure 62. Global Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn 96 Figure 63. Global Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn 97 Figure 64. Breakdown of Global Clinical Trials Market by End User, 2021-2031, % of Revenue 98 Figure 65. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 99 Figure 66. Global Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn 100 Figure 67. Global Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn 101 Figure 68. Global Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn 102 Figure 69. Global Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn 103 Figure 70. Global Market Snapshot by Region 104 Figure 71. Geographic Spread of Worldwide Clinical Trials Market, 2021-2031, % of Sales Revenue 105 Figure 72. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 106 Figure 73. North American Clinical Trials Market, 2021-2031, $ mn 109 Figure 74. Breakdown of North America Clinical Trials Market by Country, 2021 and 2031, % of Revenue 110 Figure 75. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 111 Figure 76. U.S. Clinical Trials Market, 2021-2031, $ mn 113 Figure 77. Canada Clinical Trials Market, 2021-2031, $ mn 115 Figure 78. Clinical Trials Market in Mexico, 2021-2031, $ mn 117 Figure 79. European Clinical Trials Market, 2021-2031, $ mn 120 Figure 80. Breakdown of European Clinical Trials Market by Country, 2021 and 2031, % of Revenue 121 Figure 81. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 122 Figure 82. Clinical Trials Market in Germany, 2021-2031, $ mn 123 Figure 83. Clinical Trials Market in U.K., 2021-2031, $ mn 125 Figure 84. Clinical Trials Market in France, 2021-2031, $ mn 127 Figure 85. Clinical Trials Market in Spain, 2021-2031, $ mn 129 Figure 86. Clinical Trials Market in Italy, 2021-2031, $ mn 131 Figure 87. Clinical Trials Market in Russia, 2021-2031, $ mn 133 Figure 88. Clinical Trials Market in Rest of Europe, 2021-2031, $ mn 135 Figure 89. Asia-Pacific Clinical Trials Market, 2021-2031, $ mn 138 Figure 90. Breakdown of APAC Clinical Trials Market by Country, 2021 and 2031, % of Revenue 138 Figure 91. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 140 Figure 92. Clinical Trials Market in Japan, 2021-2031, $ mn 142 Figure 93. Clinical Trials Market in China, 2021-2031, $ mn 144 Figure 94. Clinical Trials Market in Australia, 2021-2031, $ mn 146 Figure 95. Clinical Trials Market in India, 2021-2031, $ mn 148 Figure 96. Clinical Trials Market in South Korea, 2021-2031, $ mn 150 Figure 97. Clinical Trials Market in Rest of APAC, 2021-2031, $ mn 152 Figure 98. South America Clinical Trials Market, 2021-2031, $ mn 155 Figure 99. Breakdown of South America Clinical Trials Market by Country, 2021 and 2031, % of Revenue 155 Figure 100. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 156 Figure 101. Clinical Trials Market in Argentina, 2021-2031, $ mn 157 Figure 102. Clinical Trials Market in Brazil, 2021-2031, $ mn 159 Figure 103. Clinical Trials Market in Chile, 2021-2031, $ mn 161 Figure 104. Clinical Trials Market in Rest of South America, 2021-2031, $ mn 163 Figure 105. Clinical Trials Market in Middle East and Africa (MEA), 2021-2031, $ mn 165 Figure 106. Breakdown of MEA Clinical Trials Market by Country, 2021 and 2031, % of Revenue 165 Figure 107. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 166 Figure 108. Clinical Trials Market in UAE, 2021-2031, $ mn 167 Figure 109. Clinical Trials Market in Saudi Arabia, 2021-2031, $ mn 169 Figure 110. Clinical Trials Market in South Africa, 2021-2031, $ mn 171 Figure 111. Growth Stage of Global Clinical Trials Industry over the Forecast Period 174
Selected Key Players: 
Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)